维普中文期刊产品整合服务
108篇 您的检索式:作者名="Porter DL"
    题名 作者 年代 出处 被引量
1Chimeric antigen receptormodified T cells in chronic lymphoid leukemia 显示文摘Porter DL Levine BL Kalos M 2011N Engl J Med2011,365,8:1
2Donor leukocyte infusions after unrelated donor hematopoietic stem cell transplantation显示文摘Loren AW Porter DL 2006Curr Opin Oncol2006,18,2:1
3Chimeric antigen recep-tor- modified T cells in chronic lymphoid leukemia显示文摘Porter DL Levine BL Kalos M 2011N Engl JMed2011,365,8:1
4Post-transplant lymphoproliferative disorder:a review显示文摘Loren AW Porter DL Stadtmauer EA 0,,03:1
5The graft-versus-leukemia effects of allogeneic cell therapy显示文摘 1999Annu Rev Med1999,50,:1
6Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions显示文摘Porter DL Collins RH? Hardy C 2000Blood2000,95,4:1
7Chimeric antigen receptor- modified T ceils in chronic lymphoid leukemia 显示文摘Porter DL Levine BL Kalos M 2011N Engl J Med2011,365,8:1
8Chimeric antigen receptor T cell therapy: 25 years in the making 显示文摘Gill S Maus MV Porter DL 2015Blood Rev2015,10,3:1
9Tissue inhibitor of metalloproteinases- 1 stimulates gene expression in MDA -MB -435 human breast cancer cells by means of its ability to inhibit metalloproteinases 显示文摘Porter JF Sharma S Wilson DL 2005Breast Cancer Res Treat2005,94,2:1
10T cells with chimericantigen receptors have potent antitumor effects and can establishmemory in patients with advanced leukemia 显示文摘Kalos M Levine BL Porter DL 2011Sci Transl Med2011,3,:1
11Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia显示文摘Porter DL Levine BL Kalos M 2011N Engl J Med2011,365,8:1
12Donor leukocyte infusions for the treatment of relapsed acute leukemia after allogeneic stem cell transplantation显示文摘Loren AW Porter DL 2008Bone Marrow Transplant2008,41,:1
13T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia 显示文摘Kalos M Levine BL Porter DL 2011Sci Transl Med2011,3,95:1
14T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia显示文摘Kalos M Levine BL Porter DL 2011Sci Transl Med2011,3,95:1
15Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia显示文摘Porter DL Levine BL Kalos M 2011N Engl J Med2011,365,8:1
16Cutaneous Hodgkin's disease显示文摘Introcaso CE Kantor J Porter DL 2008J Am Acad Dermatol2008,58,2:1
17Graft-versus-tumor in-duction with donor leukocyte infusions as primary therapy for pa-tients with malignancies显示文摘Porter DL Connors JM Deerlin J 1999J Clini Onco1999,17,:1
18Graft - versus- tumor induetion with donor leukoeyte infusions as primary therapy for patients with malignaneies 显示文摘Porter DL Connors JM Van Deerlin VM 1999J Clin Oncol1999,17,4:1
19Differential analysisof ovarian and endometrial cancers identifies a methylator pheno-type 显示文摘Kolbe DL DeLoia JA Porter - Gill P 2012PLoS One2012,7,32:1
20Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia 显示文摘Porter DL Levine BL June CH 2011N EngI J Med2011,365,8:1
返回顶部 每页显示:
共6页 首页 上一页 第1页 下一页 末页 /6 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费